232 related articles for article (PubMed ID: 36212399)
1. To bind or not to bind: Cistromic reprogramming in prostate cancer.
Shen M; Demers LK; Bailey SD; Labbé DP
Front Oncol; 2022; 12():963007. PubMed ID: 36212399
[TBL] [Abstract][Full Text] [Related]
2. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.
Pomerantz MM; Li F; Takeda DY; Lenci R; Chonkar A; Chabot M; Cejas P; Vazquez F; Cook J; Shivdasani RA; Bowden M; Lis R; Hahn WC; Kantoff PW; Brown M; Loda M; Long HW; Freedman ML
Nat Genet; 2015 Nov; 47(11):1346-51. PubMed ID: 26457646
[TBL] [Abstract][Full Text] [Related]
3. FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression.
Zhao JC; Fong KW; Jin HJ; Yang YA; Kim J; Yu J
Oncogene; 2016 Aug; 35(33):4335-44. PubMed ID: 26751772
[TBL] [Abstract][Full Text] [Related]
4. Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG.
Wasmuth EV; Hoover EA; Antar A; Klinge S; Chen Y; Sawyers CL
Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8584-8592. PubMed ID: 32220959
[TBL] [Abstract][Full Text] [Related]
5. CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
Augello MA; Liu D; Deonarine LD; Robinson BD; Huang D; Stelloo S; Blattner M; Doane AS; Wong EWP; Chen Y; Rubin MA; Beltran H; Elemento O; Bergman AM; Zwart W; Sboner A; Dephoure N; Barbieri CE
Cancer Cell; 2019 Apr; 35(4):603-617.e8. PubMed ID: 30930119
[TBL] [Abstract][Full Text] [Related]
6. Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome.
Leach DA; Panagopoulos V; Nash C; Bevan C; Thomson AA; Selth LA; Buchanan G
Mol Cell Endocrinol; 2017 Jan; 439():261-272. PubMed ID: 27634452
[TBL] [Abstract][Full Text] [Related]
7. N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.
Berger A; Brady NJ; Bareja R; Robinson B; Conteduca V; Augello MA; Puca L; Ahmed A; Dardenne E; Lu X; Hwang I; Bagadion AM; Sboner A; Elemento O; Paik J; Yu J; Barbieri CE; Dephoure N; Beltran H; Rickman DS
J Clin Invest; 2019 Jul; 129(9):3924-3940. PubMed ID: 31260412
[TBL] [Abstract][Full Text] [Related]
8. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.
Chen Y; Chi P; Rockowitz S; Iaquinta PJ; Shamu T; Shukla S; Gao D; Sirota I; Carver BS; Wongvipat J; Scher HI; Zheng D; Sawyers CL
Nat Med; 2013 Aug; 19(8):1023-9. PubMed ID: 23817021
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome.
Malinen M; Niskanen EA; Kaikkonen MU; Palvimo JJ
Nucleic Acids Res; 2017 Jan; 45(2):619-630. PubMed ID: 27672034
[TBL] [Abstract][Full Text] [Related]
10. Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors.
Hankey W; Chen Z; Wang Q
Cancer Res; 2020 Jun; 80(12):2427-2436. PubMed ID: 32094298
[TBL] [Abstract][Full Text] [Related]
11. Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors.
Mazrooei P; Kron KJ; Zhu Y; Zhou S; Grillo G; Mehdi T; Ahmed M; Severson TM; Guilhamon P; Armstrong NS; Huang V; Yamaguchi TN; Fraser M; van der Kwast T; Boutros PC; He HH; Bergman AM; Bristow RG; Zwart W; Lupien M
Cancer Cell; 2019 Dec; 36(6):674-689.e6. PubMed ID: 31735626
[TBL] [Abstract][Full Text] [Related]
12. Cistromics of hormone-dependent cancer.
Lupien M; Brown M
Endocr Relat Cancer; 2009 Jun; 16(2):381-9. PubMed ID: 19369485
[TBL] [Abstract][Full Text] [Related]
13. Cistrome plasticity and mechanisms of cistrome reprogramming.
Garcia-Bassets I; Wang D
Cell Cycle; 2012 Sep; 11(17):3199-210. PubMed ID: 22895178
[TBL] [Abstract][Full Text] [Related]
14. NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.
Parolia A; Eyunni S; Verma BK; Young E; Liu L; George J; Aras S; Das CK; Mannan R; Rasool RU; Luo J; Carson SE; Mitchell-Velasquez E; Liu Y; Xiao L; Gajjala PR; Jaber M; Wang X; He T; Qiao Y; Pang M; Zhang Y; Alhusayan M; Cao X; Tavana O; Hou C; Wang Z; Ding K; Chinnaiyan AM; Asangani IA
bioRxiv; 2024 Mar; ():. PubMed ID: 38464251
[TBL] [Abstract][Full Text] [Related]
15. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
[TBL] [Abstract][Full Text] [Related]
16. Factors that influence the androgen receptor cistrome in benign and malignant prostate cells.
Copeland BT; Du J; Pal SK; Jones JO
Mol Oncol; 2019 Dec; 13(12):2616-2632. PubMed ID: 31520575
[TBL] [Abstract][Full Text] [Related]
17. The essential role of GATA transcription factors in adult murine prostate.
Xiao L; Feng Q; Zhang Z; Wang F; Lydon JP; Ittmann MM; Xin L; Mitsiades N; He B
Oncotarget; 2016 Jul; 7(30):47891-47903. PubMed ID: 27374105
[TBL] [Abstract][Full Text] [Related]
18. Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer.
Wu D; Sunkel B; Chen Z; Liu X; Ye Z; Li Q; Grenade C; Ke J; Zhang C; Chen H; Nephew KP; Huang TH; Liu Z; Jin VX; Wang Q
Nucleic Acids Res; 2014 Apr; 42(6):3607-22. PubMed ID: 24423874
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers.
Stelloo S; Bergman AM; Zwart W
Endocr Relat Cancer; 2019 May; 26(5):R267-R285. PubMed ID: 30865928
[TBL] [Abstract][Full Text] [Related]
20. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program.
Jin HJ; Zhao JC; Wu L; Kim J; Yu J
Nat Commun; 2014 May; 5():3972. PubMed ID: 24875621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
